Title

Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.

Document Type

Journal Article

Publication Date

3-4-2019

Journal

JAMA Internal Medicine

DOI

10.1001/jamainternmed.2018.7040

Comments

Epub ahead of print

Peer Reviewed

1

This document is currently not available here.

Share

COinS